Tesamorelin focuses on reducing visceral fat, MGF assists in muscle repair and growth, and Ipamorelin maintains steady growth hormone support
Clinical Impact: Clinical studies and patient observations have shown that GLP-1 agonists can lead to substantial weight loss in individuals with severe obesity, including those with genetic syndromes like BBS
For the high-achieving people we work with, the goal isnt just a number on the scale
"Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron"
These can include depression, anxiety, and self-isolation
High-risk groups include individuals with a history of clotting disorders, those who are obese, smokers, and people who lead a sedentary lifestyle